# TILT Biotherapeutics Ltd: Research, Helsinki, Finland

> TILT Biotherapeutics Ltd: TILT Biotherapeutics Ltd is a clinical-stage biotechnology company based in Helsinki, Finland, with a presence in Cambridge...

Source: https://millionrounds.com/startup/tilt-biotherapeutics-ltd (Millionrounds; every figure on the page links to its filing or article)

Finland · [Research startup](https://millionrounds.com/companies)

# TILT Biotherapeutics Ltd

TILT Biotherapeutics Ltd is a clinical-stage biotechnology company based in Helsinki, Finland, with a presence in Cambridge, Massachusetts.

Email

Funding reported Last round: Series B

Research Helsinki, Finland

Follow TILT Biotherapeutics Ltd and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Ftilt-biotherapeutics-ltd)

Company summary

- **Founded:** 2013 13 years old
- **Team:** 27 11 to 50 people
- **Funding reported:** 72.3M as listed, currency not stated
- **Last round:** Series B May 2025

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for TILT Biotherapeutics Ltd has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About TILT Biotherapeutics Ltd

TILT Biotherapeutics Ltd is a clinical-stage biotechnology company based in Helsinki, Finland, with a presence in Cambridge, Massachusetts.

Founded in 2013, the company focuses on developing innovative cancer immunotherapies, particularly through its proprietary TILT® technology platform. This platform utilizes oncolytic adenoviruses to activate T cells and target cancer cells, transforming "cold" tumors into "hot" tumors that are more susceptible to immune attack. The company has raised over EUR 72 million from various investors, including the European Innovation Council Fund and the U.S. Department of Defense. TILT Biotherapeutics is advancing its products through clinical trials, with a strong emphasis on enhancing the efficacy of existing therapies like immune checkpoint inhibitors and CAR T-cell therapy. Its target markets include hospitals, cancer treatment centers, and research institutions in Europe and the USA, aiming to provide effective treatments for patients with solid tumors, including those resistant to conventional therapies.

## What company datasets say TILT Biotherapeutics Ltd raised

Funding, as reported

Reported in all **72.3M** in the source's currency

Last round **Series B**

Last round size **24.9M**

Last round date **May 2025**

Investors listed **5**

## Founders and team

From TILT Biotherapeutics Ltd's own website: 7 on the team.

- **Aino Kalervo** Chief Executive Officer
- **Gianfranco Pittari** Chief Medical Officer
- **Hanna Kirk** MSc, VP Product Development
- **Henrik Roosvall** BSc, Head of Business Operations
- **John Goldfinch** Senior VP Clinical Operations
- **Víctor Cervera-Carrascón** PhD, VP Scientific Affairs and External Strategy
- **Julie Waras Brogren** MSc (Bus), Member of the Board of Directors

Advisers *Arto Linnervuo*

## On 3 portfolio pages

Investors who name them

- [Lifeline Ventures](https://millionrounds.com/fund/lifeline-ventures)
- [Stephen Industries](https://millionrounds.com/fund/stephen-industries)
- [Springvest Oyj](https://millionrounds.com/fund/springvest-oyj)

Each firm lists TILT Biotherapeutics Ltd on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

immune checkpoint inhibitors biotechnology research tcell therapy oncoimmunology immunotherapy oncolytic viruses solid tumors b2b cancer

Built with from their website

Google Maps WordPress.org Apache YouTube Viewport Meta Priority Hints Google Font API Microsoft Exchange MySQL Microsoft 365 Apps & Services

+8 more

Mobile Friendly Open Graph jQuery jQuery CDN Google Maps (Non Paid Users) Wordpress Microsoft Exchange Online Nginx

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 8000, 8090
- **Region:** Uusimaa
- **Revenue:** 4M a year, as listed

## Research in Finland

Startups like it

- [**Enifer** Espoo · founded 2020](https://millionrounds.com/startup/enifer-2)
- [**Volare Solutions** Helsinki · founded 2021](https://millionrounds.com/startup/volare-solutions)
- [**Valo Therapeutics Ltd** Helsinki · founded 2016](https://millionrounds.com/startup/valo-therapeutics-ltd)
- [**Linio Biotech** Helsinki · founded 2017](https://millionrounds.com/startup/linio-biotech)
- [**Boreal Bioproducts** Espoo · founded 2018](https://millionrounds.com/startup/boreal-bioproducts)
- [**KÄÄPÄ Biotech** Lohja · founded 2018](https://millionrounds.com/startup/k-p-biotech-2)
- [**Aurealis Therapeutics** Kuopio · founded 2015](https://millionrounds.com/startup/aurealis-therapeutics)
- [**Rappta Therapeutics** Helsingfors · founded 2019](https://millionrounds.com/startup/rappta-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put TILT Biotherapeutics Ltd in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)